Man Group
BEAM icon

Man Group’s Beam Therapeutics BEAM Stock Holding History

Man Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.53M Buy
+231,994
New +$6.44M 0.01% 1102
2025
Q4 		– Sell
-71,720
Closed -$1.74M – 2254
2025
Q3 		$1.74M Buy
+71,720
New +$1.43M ﹤0.01% 1471
2023
Q3 		– Sell
-65,944
Closed -$1.77M – 1632
2023
Q2 		$2.11M Buy
+65,944
New +$2.14M 0.01% 1179
2023
Q1 		– Hold
0
– – – 1680
2022
Q2 		– Sell
-11,698
Closed -$465K – 919
2022
Q1 		$670K Buy
+11,698
New +$767K ﹤0.01% 1494
2021
Q2 		– Sell
-6,858
Closed -$549K – 1957
2021
Q1 		$549K Buy
6,858
+4,153
+154% +$395K ﹤0.01% 1453
2020
Q4 		$220K Buy
+2,705
New +$133K ﹤0.01% 1717

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Man Group's BEAM Position: Q1 2026 in Review

Man Group opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 231,994 shares worth $5.53M. The stake represents 0.01% of the portfolio and ranks #1102 among its holdings. This is a return to the name: Man Group previously reported a position in BEAM as recently as Q3 2025.

Man Group first reported a position in BEAM in Q4 2020 and has held it in 6 quarters since. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Man Group held 231,994 shares of Beam Therapeutics worth $5.53M as of Q1 2026.
  • Beam Therapeutics was a new Man Group position in Q1 2026.
  • Beam Therapeutics made up 0.01% of Man Group's portfolio in Q1 2026, its #1102 holding.
  • Man Group first reported a position in Beam Therapeutics in Q4 2020 and has held it in 6 quarters since.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.